Zogenix (NASDAQ: ZGNX) announced it has submitted to the U.S. Food and Drug Administration (FDA) a supplemental New Drug Application ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE